12/06/2024
3:36 PM | Indaptus Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/22/2024
3:48 PM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
7:05 AM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:21 PM | Indaptus Therapeutics (Filer)
| Form D/A | |
09/22/2024
11:15 PM | Indaptus Therapeutics (Filer)
| Form EFFECT | |
09/12/2024
3:45 PM | Indaptus Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/22/2024
9:06 AM | Indaptus Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
|
08/12/2024
7:00 AM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:01 AM | Indaptus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:16 AM | Indaptus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/08/2024
4:30 PM | Indaptus Therapeutics (Issuer)
Meckler Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:00 AM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
4:28 PM | Indaptus Therapeutics (Filer)
| Form 424B5 | |
08/06/2024
4:23 PM | Indaptus Therapeutics (Filer)
| Form 424B5 | |
06/07/2024
3:30 PM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
7:00 AM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:05 AM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:06 AM | Indaptus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
8:00 AM | Indaptus Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
8:05 AM | Indaptus Therapeutics (Filer)
| Form DEFA14A | |
03/25/2024
7:31 AM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:00 PM | Indaptus Therapeutics (Filer)
| Form 424B5 | |
03/13/2024
7:00 AM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:02 AM | Indaptus Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
10:01 AM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
3:15 PM | Indaptus Therapeutics (Issuer)
Newman Michael James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:15 PM | Indaptus Therapeutics (Issuer)
Meckler Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:15 PM | Indaptus Therapeutics (Issuer)
Sassi Nir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:15 PM | Indaptus Therapeutics (Issuer)
Waltzman Roger J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:15 PM | Indaptus Therapeutics (Issuer)
Linscott Walt Addison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:05 PM | Indaptus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
